Verastem Oncology
VSTM
$11.42
Share price
-3.55%
Change (1 day)
2,619.05%
Change (1 year)
Categories
Earnings for Verastem Oncology (VSTM)
Earnings in 2023 (TTM): -$87.37 M
According to Verastem Oncology 's latest financial reports the company's current earnings (TTM) are -$87.37 M. In 2022 the company made an earning of -$73.82 M a decrease over its 2021 earnings that were of -$71.2 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Verastem Oncology from 2011 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$87.37 M | 18.36% |
| 2022 | -$73.82 M | 3.67% |
| 2021 | -$71.2 M | 5.43% |
| 2020 | -$67.54 M | -54.74% |
| 2019 | -$0.15 B | 105.99% |
| 2018 | -$72.44 M | 6.83% |
| 2017 | -$67.81 M | 86.06% |
| 2016 | -$36.44 M | -37.03% |
| 2015 | -$57.87 M | 8.43% |
| 2014 | -$53.37 M | 29.52% |
| 2013 | -$41.21 M | 28.6% |
| 2012 | -$32.04 M | 133.9% |
| 2011 | -$13.7 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $3.26 B | -3,839.40% | 🇺🇸 USA |
 LabCorp LH | $0.78 B | -1,004.00% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.88 B | -7,980.69% | 🇬🇧 UK |
 Curis CRIS | -$43.93 M | -49.72% | 🇺🇸 USA |